VOLUME 25

First Page		Document Content
Date: 2007-02-09 13:49:04 Ribbon symbolism Adjuvant therapy Acute myeloid leukemia Myelodysplastic syndrome Cyclophosphamide Chemotherapy Breast cancer treatment Mitoxantrone Docetaxel Medicine Oncology Cancer treatments		VOLUME 25 Add to Reading List Source URL: jco.ascopubs.org Download Document from Source Website File Size: 120,47 KB Share Document on Facebook

	Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators DocID: 1fWCE - View Document
	Microsoft Word[removed]abiraterone ZYTIGA JANSSEN PSD[removed]FINAL.doc DocID: XI6f - View Document
	PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application DocID: Xp3I - View Document
	Microsoft Word - Abiraterone ZYTIGA Janssen Cilag PSD[removed]FINAL.doc DocID: XeQT - View Document
	Deciding on Motherhood For Women Living with MS FreecallTM[removed]www.msaustralia.org.au DocID: Wv3D - View Document